Reference6 articles.
1. Myasthenia gravis: from autoantibodies to therapy;Mantegazza;Curr Opin Neurol,2018
2. FcRn: the neonatal Fc receptor comes of age;Roopenian;Nat Rev Immunol,2007
3. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study;Bril;Lancet Neurol,2023
4. Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study;Howard;Lancet Neurol,2023
5. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial;Howard;Lancet Neurol,2021
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献